Lawrence D. Wise - Concepedia

Author

Lawrence D. Wise

Also Known As

L D Wise, L Wise, L. D. WISE, L. WISE, L. Wise, L.D Wise, L.D. Wise, Lawrence D Wise, Lawrence D. Wise, Lawrence David Wise

111

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Warde Medical Laboratory University of Groningen Gaertner (United States)

About

Lawrence D. Wise is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	1.8K
2	Natural Sciences	14	16	1.1K
3	Engineering	7	7	167
4	Social Sciences	7	7	260
5	Health Sciences	1	1	33

Lawrence D. Wise

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties Juan C. Jaén, Lawrence D. Wise, Bradley W. Caprathe, Journal of Medicinal Chemistry Active DopamineOrganic ChemistryPharmacotherapyChemistryHeterocycle Chemistry	1990	254
Isoindolinone enantiomers having affinity for the dopamine D4 receptor Thomas R. Belliotti, Wouter A. Brink, Suzanne R. Kesten, Bioorganic & Medicinal Chemistry Letters Isoindolinone EnantiomersFunctional SelectivityMedicineNeuropharmacologyPharmacotherapy	1998	209
Structure−Activity Relationships of Pregabalin and Analogues That Target the α<sub>2</sub>-δ Protein Thomas R. Belliotti, Thomas Capiris, I. Victor Ekhato, Journal of Medicinal Chemistry NeurotransmitterMolecular BiologyChemical BiologyExperimental PharmacologyPregabalin Analogues	2005	208
Autoradiographic localisation of D 3 -dopamine receptors in the human brain using the selective D 3 -dopamine receptor agonist (+)-[ 3 H]PD 128907 Håkan Hall, Christer Halldin, Durk Dijkstra, Psychopharmacology NeurophysiologyNeuroanatomyFunctional SelectivityNeuropharmacologySocial Sciences	1996	127
Design, Synthesis, and Evaluation of Chromen-2-ones as Potent and Selective Human Dopamine D4 Antagonists Suzanne R. Kesten, Thomas G. Heffner, Stephen J. Johnson, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistrySelective AffinityCompound 22Biochemistry	1999	110
Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines Jonathan L. Wright, Tracy F. Gregory, Suzanne R. Kesten, Journal of Medicinal Chemistry	2000	110
Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D<sub>4</sub> Agonists Shelly A. Glase, Hyacinth C. Akunne, Lynn M. Georgic, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceBiochemistry	1997	105
Subtype-Selective <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines Jon L. Wright, Tracy F. Gregory, Christopher F. Bigge, Journal of Medicinal Chemistry	1999	95
Affinity for Dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub>Receptors of 2-Aminotetralins. Relevance of D<sub>2</sub>Agonist Binding for Determination of Receptor Subtype Selectivity L. Alexander van Vliet, Pieter G. Tepper, Durk Dijkstra, Journal of Medicinal Chemistry Receptor Subtype SelectivityPharmacotherapyReasonable SelectivityMolecular PharmacologyMedicinal Chemistry	1996	68
Chromeno[3,4-<i>c</i>]pyridin-5-ones: Selective Human Dopamine D<sub>4</sub> Receptor Antagonists as Potential Antipsychotic Agents Paul C. Unangst, Thomas Capiris, David T. Connor, Journal of Medicinal Chemistry Selective AffinityPsychotropic MedicationPsychopharmacologyMolecular PharmacologyMedicinal Chemistry	1997	62

Page 1